U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ABSOLUTE
Molecular Formula C4H5NO4.Mg.ClH.3H2O
Molecular Weight 245.899
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MAGNESIUM ASPARTATE HYDROCHLORIDE TRIHYDRATE

SMILES

O.O.O.[Mg++].Cl.N[C@@H](CC([O-])=O)C([O-])=O

InChI

InChIKey=BBRFANCCCAUJFS-PUAMRSTPSA-L
InChI=1S/C4H7NO4.ClH.Mg.3H2O/c5-2(4(8)9)1-3(6)7;;;;;/h2H,1,5H2,(H,6,7)(H,8,9);1H;;3*1H2/q;;+2;;;/p-2/t2-;;;;;/m0...../s1

HIDE SMILES / InChI
Molecular Formula H2O
Molecular Weight 18.0153
Charge 0
Count
MOL RATIO 3 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE
Molecular Formula Mg
Molecular Weight 24.305
Charge 2
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE
Molecular Formula C4H5NO4
Molecular Weight 131.0868
Charge -2
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED
Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

Magnesium diamide is used as a chemical intermediate. Magnesium diamide is spontaneously combustible. It is toxic by inhalation. Skin or eye contact may cause severe burns.

CNS Activity

CNS Penetrant
2,588

Originator

Ulex, G.L.
66

Approval Year

1921
1,468

Targets

Primary TargetPharmacologyConditionPotency
action potential
66
Inhibitor
8,504
magnesium ion homeostasis
70
Modulator
846
magnesium ion homeostasis
70
Modulator
846
oxalate metabolic process
66
Modulator
846
magnesium ion homeostasis
70
Modulator
846
magnesium ion homeostasis
70
Interacts
323
Protein S100-A8
66
Binding Agent
1,076

Conditions

ConditionModalityTargetsHighest PhaseProduct
Bone disease
70
 Primary
Basic research
Unknown
Bacterial infections
235
 Primary
Preclinical
Unknown
Bronchial spasm
78
 Primary
Preclinical
Unknown
Preeclampsia
85
 Preventing
Approved
8,583
MAGNESIUM SULFATE
Eclampsia
69
 Primary
Approved
8,583
MAGNESIUM SULFATE
Preparation for colonoscopy
66
 Diagnostic
Approved
8,583
ColPrep Kit
Atrial fibrillation
131
 Primary
Phase III
665
MAGNESIUM SULFATE
Magnesium deficiency
67
 Curative
Approved
8,583
MagMin
Magnesium deficiency
67
 Curative
Not Provided
511
DELBIASE
Eclampsia
69
 Primary
Not Provided
511
DELBIASE
Convulsions
72
 Primary
Not Provided
511
DELBIASE
Magnesium deficiency
67
 Curative
Approved
8,583
Magnesium Chloride
Fibromyalgia
90
 Palliative
Phase II
1,147
Magnesium Chloride
Stroke
144
 Palliative
Phase III
665
Magnesium Chloride
Oxaluria
66
 Primary
Approved
8,583
EPIMAG
Constipation
112
 Primary
Approved
8,583
EPIMAG
Magnesium deficiency
67
 Curative
Approved
8,583
Magnesium Citrate
Magnesium deficiency
67
 Curative
Approved
8,583
Unknown

PubMed

Patents

03931199
72
03931205
77
03931302
69
03932463
70
03932472
89
03932479
113
03932483
75
03932524
68
03933824
70
03935253
66
03935271
69
03936470
98
03939091
68
03944589
66
03950406
119
03950427
70
03950525
67
03957788
66
03960906
66
03960907
67
03961066
66
03963724
66
03965143
66
03966648
67
03966773
135
03968231
67
03969368
66
03969384
66
03973022
77
03973030
67
03978121
74
03978129
66
03978130
66
03980795
66
03981917
74
03982001
66
03983164
67
03985729
66
03985817
66
03987009
96
03987091
67
03988205
66
03989724
72
03989749
68
03989841
66
03991106
66
03993773
66
03994961
66
03995054
67
03995056
70
03998834
70
04005147
106
04045433
67
04059595
66
04088772
67
04144333
66
04156786
66
04289816
66
04341767
67
04454357
66
04471070
66
04540815
66
04546195
66
04569941
66
04577011
67
04585885
67
04599341
66
04661260
68
04725688
68
04734420
74
04916235
70
04935430
66
04990319
66
05012019
66
05177240
66
05206229
66
05275950
67
05326548
66
05389640
67
05451591
67
05633237
66
05658908
68
05719148
82
05786353
67
05859290
66
05929067
67
06017928
73
06040331
66
06051712
73
06100275
67
06150526
73
06156767
66
06274737
68
06380218
73
06540905
67
06613708
66
06812355
66
07230017
69
07402595
70
07445915
66
07557213
67
07601736
66
07691842
69
08236943
66
08383835
66
20050130276
66
20060100207
66
20100267970
66
CN106582743
66
DE1110825
66
EP1810974A1
66
EP2259773A1
66
EP2708510A1
66
EP2714042A1
66
US1913539
66
US20060083725
66
US20140076804
66
US2034070
66
US2260004
66
US2877095
66
US3030184
66
US3320048
66
US3377271
66
US3429777
66
US3476510
66
US3760050
66
US3994859
66
US4111835
66
US4535183
66
US4748283
66
US4959222
66
US7182872
66
US7608239
66
US9334166
66
WO2000050046A1
66
WO2005123647A1
68

Sample Use Guides

In Vivo Use Guide
Magnesium lactate is used as a dietary supplement (200-400 mg of elemental magnesium per day for adults).
Route of Administration: Oral
In Vitro Use Guide
Unknown
Substance Class Chemical
Record UNII
B06NP3KG40
Record Status Validated (UNII)
Record Version
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966